Levitra has long been overshadowed by its competitors Viagra and Cialis due to poor advertising carried out prior to and following its launch. This has meant that despite being a highly effective drug with relatively fewer side effects compared to other medicines it is less sought after. Levitra sales make up less than 15% of all revenue gained on orally administered erectile dysfunction medicines leaving Cialis and Viagra mammoth shares of the market. This statistic is also reflected online market where acheter Levitra Vardenafil 20mg en ligne represents just 6-8% of sales.
Bayer’s woes are directly related to the pharmaceutical giant’s inability to carve a niche in the ED market. For Pfizer advertising Viagra was a relatively easy affair. The iconic blue pill shot to fame as the first ever ED pill and instantly became hailed as a wonder drug. Viagra held a monopoly on the ED market for several years and was the hotly discussed both in the medical world and in popular culture. This particular set of circumstances placed Viagra firmly on our lips and etched the brand into our minds. Such is the power of the Pfizer brand, that Viagra is still one of the most searched for terms on the net. Competitors Lilly created an edge by launching the “weekender”, a pill capable of lasting up to 36 hours. The treatment branded as Cialis, is hailed as a wonder drug: something to admire and be fearful of at the same time. Cialis was an instant success and tales of its long lasting-effects have ensured it is now the most requested ED drug amongst those who have never used any treatment of this kind before.
So what happened with Levitra? Levitra essentially ended up as the overlooked middle child, with no special characteristics going for it other than a relative greater tolerance to its ingredients. Its milder character does little to entice potential customers who are looking for a pill to enhance their sex lives especially when constantly compared to its louder, more interesting siblings.
